Wang Chao, Zhang Hong-Bin, Li Meng-Qi, Hu Xue-Qin, Li Yao
School of Biological and Medical Engineering, Hefei University of Technology, 193# Tunxi Road, Hefei 230009, Anhui Province, P. R. China.
School of Biological and Medical Engineering, Hefei University of Technology, 193# Tunxi Road, Hefei 230009, Anhui Province, P. R. China.
Enzyme Microb Technol. 2017 Jul;102:26-34. doi: 10.1016/j.enzmictec.2017.03.011. Epub 2017 Mar 25.
Dextrans with distinct molecular size and structure are increasingly being used in the food and pharmaceutical industries. Dextran is produced by dextransucrase (DSR, EC2.4.5.1), which is produced by Leuconostoc mesenteroides. DSR belongs to glycosyl hydrolase family (GH70) and synthesizes branched α-glucan (dextran) with both 5% α(1-3) and 95% α(1-6) glycosidic linkages. The DSR gene dex-YG (Genebank, Accession No. DQ345760) was cloned from the wild strain Leuconostoc mesenteroides 0326. This study generated a series of C-terminally truncated variants of dextransucrase and substituting the amino-acid residues in the active site of DSR. With shorter length of DSR, its polysaccharide-synthesizing capability was impaired heavily, whereas oligosaccharide (acting as prebiotics)-synthesizing capability increased significantly, efficiently producing special sizes of dextran. All truncated mutant enzymes were active. Results demonstrated that the catalytic domain dextransucrase was likely in 800 aa or less. Based on the three-dimensional structure model of dextransucrase built through homology modeling methods, the DSR and its mutants with the acceptor substrate of maltose and donor substrate of sucrose were studied by molecular-docking method. Substituting these amino-acid residues significantly affected enzyme activities. Compared with the wild-type dextran, mutant enzymes catalyzed the synthesis of a-glucan with 1-9% α(1-3) and 90-98% α(1-6) branching linkages. Some mutants introduced a small amount of α(1-4) linkages and α(1-2) linkages. This strategy can be effectively used for the rational protein design of dextransucrase.
具有不同分子大小和结构的葡聚糖在食品和制药行业中的应用越来越广泛。葡聚糖由肠系膜明串珠菌产生的葡聚糖蔗糖酶(DSR,EC2.4.5.1)合成。DSR属于糖基水解酶家族(GH70),能合成具有5%α(1-3)和95%α(1-6)糖苷键的分支α-葡聚糖(葡聚糖)。从野生菌株肠系膜明串珠菌0326中克隆了DSR基因dex-YG(基因库,登录号DQ345760)。本研究生成了一系列葡聚糖蔗糖酶C末端截短变体,并替换了DSR活性位点中的氨基酸残基。随着DSR长度缩短,其多糖合成能力严重受损,而寡糖(作为益生元)合成能力显著提高,能高效产生特殊大小的葡聚糖。所有截短突变酶均具有活性。结果表明,葡聚糖蔗糖酶的催化结构域可能在800个氨基酸及以下。基于通过同源建模方法构建的葡聚糖蔗糖酶三维结构模型,采用分子对接方法研究了以麦芽糖为受体底物、蔗糖为供体底物的DSR及其突变体。替换这些氨基酸残基显著影响酶活性。与野生型葡聚糖相比,突变酶催化合成的α-葡聚糖具有1-9%的α(1-3)和90-98%的α(1-6)分支连接。一些突变体引入了少量的α(1-4)连接和α(1-2)连接。该策略可有效用于葡聚糖蔗糖酶的合理蛋白质设计。